Emmaus Life Sciences' Debt Round

Emmaus Life Sciences raised a round of funding on January 18, 2018. Investors include GPB Capital Holdings.

Emmaus Life Sciences is a biopharmaceutical company engaged in the discovery, development and commercialization of innovative treatments and therapies primarily for rare and orphan disease. The compan…

Articles about Emmaus Life Sciences' Debt Round: